Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4).
Philip D HomeRichard M BergenstalGeremia B BolliMonika ZiemenMaria RojeskiMelanie EspinasseMatthew C RiddlePublished in: Diabetes, obesity & metabolism (2017)
In T1DM, Gla-300 provides glucose control comparable to that of Gla-100, and can be given at any time of day.